|
Partner, Pappas Venutures. Mr. Klausner recently joined AMP&A as a
Partner. From 1990 through February 2004, Mr. Klausner was with Domain
Associates, a venture capital firm specializing in life sciences companies,
serving as a General Partner from 1997 through February 2004. During that
time, he was a board member of Domain portfolio companies such as
Santarus (IPO in 2004), X-Ceptor (acquired by Exelixis), and Altea
Therapeutics, and he was a board observer for Peninsula Pharmaceuticals
(acquired by Johnson & Johnson). Previously, Mr. Klausner spent six years
at Bio/Technology magazine (now Nature Biotechnology), where as Senior
Editor he researched and prepared over 200 articles concerning scientific
and business aspects of applied biology. Mr. Klausner holds a BA in Biology
from Princeton University and an MBA from Stanford University.
| 